These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11377704)

  • 41. Modeling of main characteristics of bullous pemphigoid antigen-2 (BPAG2) peptide structure in serological recognition by autoantibodies.
    Pál J; Marczinovits I; Hudecz F; Tóth GK; Mezõ G; Molnár J; Németh P
    Pathol Oncol Res; 2004; 10(1):52-6. PubMed ID: 15029263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model.
    Ujiie H; Shibaki A; Nishie W; Shinkuma S; Moriuchi R; Qiao H; Shimizu H
    Clin Immunol; 2012 Feb; 142(2):167-75. PubMed ID: 22044750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bullous pemphigoid of childhood: immunofluorescent investigation.
    Tamaki K; Igarashi A; Nakamura K; Nashiro K; Okochi H; Seki Y; Tsuchida T
    J Dermatol; 1988 Oct; 15(5):400-4. PubMed ID: 3065382
    [No Abstract]   [Full Text] [Related]  

  • 44. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens.
    Ghohestani RF; Nicolas JF; Kanitakis J; Claudy A
    J Invest Dermatol; 1997 Jun; 108(6):854-8. PubMed ID: 9182810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A case of bullous pemphigoid with antidesmoplakin autoantibodies.
    Watanabe K; Hashimoto T; Ishiko A; Shimizu H; Nishikawa T
    Dermatology; 1994; 189 Suppl 1():126-8. PubMed ID: 8049553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bullous pemphigoid antigen localization suggests an intracellular association with hemidesmosomes.
    Westgate GE; Weaver AC; Couchman JR
    J Invest Dermatol; 1985 Mar; 84(3):218-24. PubMed ID: 2579167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complementary peptides against the major epitope in the NC16A domain of BP180 show no specificity as vaccines to bullous pemphigoid.
    Nie Z; Garrod DR; Chan LS; Hashimoto T
    J Dermatol Sci; 1999 Nov; 21(3):157-64. PubMed ID: 10527376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls.
    Büdinger L; Borradori L; Yee C; Eming R; Ferencik S; Grosse-Wilde H; Merk HF; Yancey K; Hertl M
    J Clin Invest; 1998 Dec; 102(12):2082-9. PubMed ID: 9854043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
    Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
    Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
    Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
    Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pemphigoid gestationis without blisters].
    Ogilvie P; Trautmann A; Dummer W; Rose C; Bröcker EB; Zillikens D
    Hautarzt; 2000 Jan; 51(1):25-30. PubMed ID: 10663036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pemphigoid nodularis: a case with 230 kDa hemidesmosomes antigen associated with bullous pemphigoid antigen.
    Tamada Y; Yokochi K; Oshitani Y; Nitta Y; Ikeya T; Hara K; Owaribe K
    J Dermatol; 1995 Mar; 22(3):201-4. PubMed ID: 7738277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Canine bullous pemphigoid (BP): identification of the 180-kd canine BP antigen by circulating autoantibodies.
    Iwasaki T; Olivry T; Lapiere JC; Chan LS; Peavey C; Liu YY; Jones JC; Ihrke PJ; Woodley DT
    Vet Pathol; 1995 Jul; 32(4):387-93. PubMed ID: 7483213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the antibody response in oesophageal cicatricial pemphigoid.
    Egan CA; Hanif N; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ
    Br J Dermatol; 1999 May; 140(5):859-64. PubMed ID: 10354023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a 160-kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen.
    Zhu XJ; Niimi Y; Bystryn JC
    J Invest Dermatol; 1990 Jun; 94(6):817-21. PubMed ID: 1693941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immediate hypersensitivity phenomena in bullous pemphigoid: critical concepts.
    Bowszyc-Dmochowska M; Dmochowski M
    J Med; 2002; 33(1-4):189-98. PubMed ID: 12939118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins.
    Nakatani C; Muramatsu T; Shirai T
    Br J Dermatol; 1998 Sep; 139(3):365-70. PubMed ID: 9767278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical significance of enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid.
    Amo Y; Ohkawa T; Tatsuta M; Hamada Y; Fujimura T; Katsuoka K; Hashimoto T
    J Dermatol Sci; 2001 May; 26(1):14-8. PubMed ID: 11323216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid.
    Delaporte E; Dubost-Brama A; Ghohestani R; Nicolas JF; Neyrinck JL; Bergoend H; Janin A; Capron M
    J Immunol; 1996 Oct; 157(8):3642-7. PubMed ID: 8871665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen.
    Domloge-Hultsch N; Utecht L; James W; Yancey KB
    Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.